Vivian Medithi is a freelance writer and critic with bylines at Guardian US, LA Review of Books and No Bells, among others. He previously covered the stock market as an Analyst Editor at InvestorPlace ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

UiPath's competitive edge lies in its AI integration, SAP partnership and industry-agnostic automation solutions, making it a strong contender in RPA despite generative AI threats. Recent struggles ...

Automation has evolved. Where a decade ago we were happy (if not positively exhilarated) to talk about the application of intelligent document processing and robotic process automation as progressive ...

Software developer UiPath will cut 10% of its workforce, or about 420 jobs, as part of a broader company restructuring. UiPath shares fell 7% on Tuesday and have plunged more than 50% year-to-date. In ...

UiPath's software automates menial digital tasks, freeing people up for more meaningful jobs. This sounds an awful lot like one of the benefits of generative AI, which explains customers' confusion.

Reporting Q3 2026 revenue of $411 million, UiPath achieved a 16% year-over-year increase on the top line and surpassed analysts' expectations that it would report sales of $392.9 million. At the ...